Cargando…

The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study

BACKGROUND AND OBJECTIVES: With the increase in the number of COVID-19 infections, the global health apparatus is facing insufficient resources. The main objective of the current study is to provide additional data regarding the clinical characteristics of the patients diagnosed with COVID-19, and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fathi, Mobina, Vakili, Kimia, Sayehmiri, Fatemeh, Mohamadkhani, Ashraf, Hajiesmaeili, Mohammadreza, Rezaei-Tavirani, Mostafa, Eilami, Owrang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886178/
https://www.ncbi.nlm.nih.gov/pubmed/33592019
http://dx.doi.org/10.1371/journal.pone.0246190
_version_ 1783651745251983360
author Fathi, Mobina
Vakili, Kimia
Sayehmiri, Fatemeh
Mohamadkhani, Ashraf
Hajiesmaeili, Mohammadreza
Rezaei-Tavirani, Mostafa
Eilami, Owrang
author_facet Fathi, Mobina
Vakili, Kimia
Sayehmiri, Fatemeh
Mohamadkhani, Ashraf
Hajiesmaeili, Mohammadreza
Rezaei-Tavirani, Mostafa
Eilami, Owrang
author_sort Fathi, Mobina
collection PubMed
description BACKGROUND AND OBJECTIVES: With the increase in the number of COVID-19 infections, the global health apparatus is facing insufficient resources. The main objective of the current study is to provide additional data regarding the clinical characteristics of the patients diagnosed with COVID-19, and in particular to analyze the factors associated with disease severity, lack of improvement, and mortality. METHODS: 102 studies were included in the present meta-analysis, all of which were published before September 24, 2020. The studies were found by searching a number of databases, including Scopus, MEDLINE, Web of Science, and Embase. We performed a thorough search from early February until September 24. The selected papers were evaluated and analyzed using Stata software application version 14. RESULTS: Ultimately, 102 papers were selected for this meta- analysis, covering 121,437 infected patients. The mean age of the patients was 58.42 years. The results indicate a prevalence of 79.26% for fever (95% CI: 74.98–83.26; I(2) = 97.35%), 60.70% for cough (95% CI: 56.91–64.43; I(2) = 94.98%), 33.21% for fatigue or myalgia (95% CI: 28.86–37.70; I(2) = 96.12%), 31.30% for dyspnea (95% CI: 26.14–36.69; I(2) = 97.67%), and 10.65% for diarrhea (95% CI: 8.26–13.27; I(2) = 94.20%). The prevalence for the most common comorbidities was 28.30% for hypertension (95% CI: 23.66–33.18; I(2) = 99.58%), 14.29% for diabetes (95% CI: 11.88–16.87; I(2) = 99.10%), 12.30% for cardiovascular diseases (95% CI: 9.59–15.27; I(2) = 99.33%), and 5.19% for chronic kidney disease (95% CI: 3.95–6.58; I(2) = 96.42%). CONCLUSIONS: We evaluated the prevalence of some of the most important comorbidities in COVID-19 patients, indicating that some underlying disorders, including hypertension, diabetes, cardiovascular diseases, and chronic kidney disease, can be considered as risk factors for patients with COVID-19 infection. Furthermore, the results show that an elderly male with underlying diseases is more likely to have severe COVID-19.
format Online
Article
Text
id pubmed-7886178
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-78861782021-02-23 The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study Fathi, Mobina Vakili, Kimia Sayehmiri, Fatemeh Mohamadkhani, Ashraf Hajiesmaeili, Mohammadreza Rezaei-Tavirani, Mostafa Eilami, Owrang PLoS One Research Article BACKGROUND AND OBJECTIVES: With the increase in the number of COVID-19 infections, the global health apparatus is facing insufficient resources. The main objective of the current study is to provide additional data regarding the clinical characteristics of the patients diagnosed with COVID-19, and in particular to analyze the factors associated with disease severity, lack of improvement, and mortality. METHODS: 102 studies were included in the present meta-analysis, all of which were published before September 24, 2020. The studies were found by searching a number of databases, including Scopus, MEDLINE, Web of Science, and Embase. We performed a thorough search from early February until September 24. The selected papers were evaluated and analyzed using Stata software application version 14. RESULTS: Ultimately, 102 papers were selected for this meta- analysis, covering 121,437 infected patients. The mean age of the patients was 58.42 years. The results indicate a prevalence of 79.26% for fever (95% CI: 74.98–83.26; I(2) = 97.35%), 60.70% for cough (95% CI: 56.91–64.43; I(2) = 94.98%), 33.21% for fatigue or myalgia (95% CI: 28.86–37.70; I(2) = 96.12%), 31.30% for dyspnea (95% CI: 26.14–36.69; I(2) = 97.67%), and 10.65% for diarrhea (95% CI: 8.26–13.27; I(2) = 94.20%). The prevalence for the most common comorbidities was 28.30% for hypertension (95% CI: 23.66–33.18; I(2) = 99.58%), 14.29% for diabetes (95% CI: 11.88–16.87; I(2) = 99.10%), 12.30% for cardiovascular diseases (95% CI: 9.59–15.27; I(2) = 99.33%), and 5.19% for chronic kidney disease (95% CI: 3.95–6.58; I(2) = 96.42%). CONCLUSIONS: We evaluated the prevalence of some of the most important comorbidities in COVID-19 patients, indicating that some underlying disorders, including hypertension, diabetes, cardiovascular diseases, and chronic kidney disease, can be considered as risk factors for patients with COVID-19 infection. Furthermore, the results show that an elderly male with underlying diseases is more likely to have severe COVID-19. Public Library of Science 2021-02-16 /pmc/articles/PMC7886178/ /pubmed/33592019 http://dx.doi.org/10.1371/journal.pone.0246190 Text en © 2021 Fathi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fathi, Mobina
Vakili, Kimia
Sayehmiri, Fatemeh
Mohamadkhani, Ashraf
Hajiesmaeili, Mohammadreza
Rezaei-Tavirani, Mostafa
Eilami, Owrang
The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
title The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
title_full The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
title_fullStr The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
title_full_unstemmed The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
title_short The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
title_sort prognostic value of comorbidity for the severity of covid-19: a systematic review and meta-analysis study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886178/
https://www.ncbi.nlm.nih.gov/pubmed/33592019
http://dx.doi.org/10.1371/journal.pone.0246190
work_keys_str_mv AT fathimobina theprognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT vakilikimia theprognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT sayehmirifatemeh theprognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT mohamadkhaniashraf theprognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT hajiesmaeilimohammadreza theprognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT rezaeitaviranimostafa theprognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT eilamiowrang theprognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT fathimobina prognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT vakilikimia prognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT sayehmirifatemeh prognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT mohamadkhaniashraf prognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT hajiesmaeilimohammadreza prognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT rezaeitaviranimostafa prognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy
AT eilamiowrang prognosticvalueofcomorbidityfortheseverityofcovid19asystematicreviewandmetaanalysisstudy